SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-019415
Filing Date
2020-04-29
Accepted
2020-04-29 06:53:33
Documents
3
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A urgn-defa14a_20200608.htm DEFA14A 32896
2 GRAPHIC g5s3tnulnuxz000002.jpg GRAPHIC 81502
3 GRAPHIC g5s3tnulnuxz000001.jpg GRAPHIC 88830
  Complete submission text file 0001564590-20-019415.txt   268726
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38079 | Film No.: 20827272
SIC: 2834 Pharmaceutical Preparations